Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

TB drug may cure Parkinson-type symptoms of manganese intoxication

Researchers have discovered that a drug used to treat tuberculosis apparently cures patients of a Parkinson's-like illness suffered by thousands of mineworkers, welders and others exposed to high levels of the metal manganese.

7 Jun 2006

PET imaging of cerebral cannabinoid CB1 receptors with [11C]JHU75528

A team of Johns Hopkins researchers developed a new radiotracer - a radioactive substance that can be traced in the body - to visualize and quantify the brain's cannabinoid receptors by positron emission tomography (PET).

6 Jun 2006

Calpain protein key to preventing or promoting cell death

A protein called calpain can be the key either preventing or promoting the cell death, a Queen's University study has found.

6 Jun 2006

Sleeping pill rouses people in a permanent vegetative state

South African researchers have found that a drug commonly used as a sleeping pill can temporarily revive people in a permanent vegetative state to the point where they can have conversations.

25 May 2006

Researchers identify target of the widely prescribed antidepressant Prozac

Researchers at Cold Spring Harbor Laboratory on Long Island have identified which among several different kinds of cells in the brain is the chief target of the widely prescribed antidepressant Prozac.

23 May 2006

New drug for Parkinson's gets FDA approval

The Food and Health Administration in the U.S. has granted approval for a new drug to treat patients with Parkinson's disease.

21 May 2006

FDA approves Azilect for the treatment of Parkinson's

The Food and Drug Administration today approved Azilect (rasagiline), a new molecular entity, for the treatment of Parkinson's disease.

17 May 2006

Oxygen free radicals associated with Parkinson's Disease

Research by neuroscientists at the University of Virginia Health System shows that oxygen free radicals are damaging proteins in mitochondria, the tiny cellular 'batteries' of brain cells.

17 May 2006

German scientists synthesize new compound that reduces stroke damage

A group of German scientists has synthesized a new compound that dramatically decreases the damage to neurons in rats demonstrating stroke symptoms.

16 May 2006

Neuren granted US patent for NNZ-2566

Neuren Pharmaceuticals has announced that its patent application entitled "GPE Analogs and Peptidomimetics" (PCT/US02/16361) has been issued in the United States (US Patent No: 7,041,314) on 9 May 2006.

10 May 2006

Obtaining and documenting informed patient consent prior to surgery

Obtaining and documenting informed patient consent prior to surgery is of vital importance, but both the process and documentation of consent can be inadequate.

3 May 2006

Study shows drugs work differently in the brains of men and women

A Johns Hopkins discovery could lead to tailored treatments for drug abuse and neurological diseases after providing what is believed to be the first evidence in people that amphetamines have a greater effect on men's brains than women's.

24 Apr 2006

Simple mobile device for people at risk

Validated for commercial use in the MobilAlarm project with funding from the European Commission's eTEN Programme, the small and simple mobile device allows users to place a call to a service centre in the event of an emergency, while satellite positioning via GPS provides information about their location with an accuracy of 50 metres or less.

23 Apr 2006

New orthostatic hypotension treatment reduces symptoms without causing high blood pressure

A drug traditionally used to treat myasthenia gravis shows potential benefit for reducing symptoms of orthostatic hypotension without raising blood pressure when people lie down, according to results of a double-blind, controlled clinical trial.

19 Apr 2006

Promising treatment for Huntington's disease soon to be tested clinically

At the Institut Curie, CNRS and Inserm researchers have shown that cysteamine, which is already used to treat a rare disease called cystinosis, prevents the death of neurons in Huntington's disease. Like Alzheimer's and Parkinson's, Huntington's disease, is characterized by the abnormal death of neurons.

19 Apr 2006

Researchers identify novel agent that protects neurons involved in Parkinson's disease from being destroyed by rotenone

Researchers at the University at Buffalo affiliated with the New York State Center of Excellence in Bioinformatics and Life Sciences have identified a novel agent that can protect neurons involved in Parkinson's disease from being destroyed by the pesticide rotenone.

18 Apr 2006

How you wake up might explain near death experiences

According to a new study, people who have had near death experiences often have different arousal systems controlling the sleep-wake states than people who have never had such an experience.

12 Apr 2006

REM state intrusion contributes to near death experiences

People who have had near death experiences often have different arousal systems controlling the sleep-wake states than people who have not had a near death experience, according to a new study published in the April 11, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.

11 Apr 2006

Genetic variants in estrogen-related genes linked to Parkinson's disease in women

Mayo Clinic researchers have discovered a possible connection between increased risk for Parkinson's disease and variants in three genes that control estrogen production and activity in the body.

11 Apr 2006

Discovery of a new mechanism for the neurodegenerative effects of amphetamines

University of Toronto study finds amphetamines are converted in the brain into free radicals whose effects manifest and linger long after the amphetamine has left the body.

7 Apr 2006